关于治疗慢性乙型肝炎的AASLD/IDSA实践指南
Marc G Ghany1, Calvin Q Pan2, Anna S Lok3
1Clinical Hepatology Research Section, Liver Diseases Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Hepatology (Baltimore, Md.)
|November 4, 2025
概括
这份更新的指南提供了基于证据的建议,用于预防,监测和治疗慢性乙型肝炎 (CHB). 它旨在优化患者护理,使用GRADE方法来治疗慢性HBV感染.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 关于慢性乙型肝炎 (CHB) 的数据越来越多,需要更新临床指南.
- 使用了推评估,开发和评估 (GRADE) 的分级方法.
- 重点领域包括CHB的预防,监测和治疗策略.
研究的目的:
- 为管理慢性乙型肝炎提供最新的,基于证据的建议.
- 解决CHB预防,监测和治疗中的关键临床问题.
- 优化CHB患者的临床护理.
主要方法:
- 准则的制定遵循了国家医学院的标准.
- 使用人口,干预,比较,结果 (PICO) 框架制定了结构化问题.
- 建议得到了四个新的系统审查和两个现有的系统审查的支持.
主要成果:
- 回答了关于CHB预防,监测和治疗的6个PICO问题.
- 提供了预防母婴和横向传播的建议.
- 包括关于特定患者群体肝癌监测和治疗中止的建议.
结论:
- 这份基于证据的指导方针为CHB护理提供了最新的建议.
- 该指南旨在优化慢性乙型肝炎患者的管理策略.
- 它是管理CHB的医疗保健专业人员的重要资源.
关键词:
停止使用抗病毒药物.灰色区域是一个灰色区域.肝细胞癌是肝细胞癌.横向传输水平传输的情况具有免疫耐受性的人.不确定的 不确定的怀孕 怀孕 怀孕 怀孕 怀孕监控监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督更多相关视频
相关概念视频
Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25


